devices.longevity.one
Atlas Neuromodulation HRV Biofeedback (Resonance Breathing, ~0.1 Hz)
Neuromodulation

HRV Biofeedback (Resonance Breathing, ~0.1 Hz)

Evidence-supportedBgradePlausibility · Plausible / established (narrow)Neuromodulation
Evidence-supported · Evidence-supported
Anxiety and stress — moderate, meta-analytic effect.
Off-label · Insufficient-evidence
Broad 'coherence' / longevity / performance claims.

The honest ceiling of the 'sensor + frequency' idea: a real measured signal, a defined active ingredient — resonance breathing at ~0.1 Hz — and a meta-analytic effect on anxiety and stress. The biofeedback loop GUIDES the breathing; the breathing is the mechanism. It belongs in the same atlas as the devices that claim a real signal, a defined mechanism, and a measured effect — and have none.

Origin & lineage
Resonance-breathing / baroreflex biofeedback lineage (Lehrer, Vaschillo, and others).
Claimed mechanism
Slow breathing at the ~0.1 Hz baroreflex resonance frequency, guided by real-time HRV feedback, increases vagal / autonomic modulation.
Plausibility
Plausible / established (narrow) — a real, measured signal and a defined active ingredient.
Evidence — grade B
Goessl 2017 (Psychol Med; within g=0.81, vs-control g=0.83, stress/anxiety); Lehrer 2020 SR+MA (58 RCTs); Pizzoli 2021 (g=0.38, depression); Lehrer 2017 (mechanism). Moderate effect for anxiety/stress; the active ingredient is resonance breathing, guided — not caused — by the feedback.
Market
Makers: HeartMath; Elite HRV; clinical biofeedback systems.
Models: emWave; Inner Balance; clinical HRVB.
Price: Consumer ~$100–300; clinical higher.

Kernel — keep vs set aside

Keep — real substrate
A real, measured autonomic signal plus a defined breathing protocol with meta-analytic support for anxiety and stress.
Set aside — claim
The feedback loop is the delivery, not the magic; broader 'coherence' / longevity / performance claims exceed the evidence.

Regulatory status by jurisdiction

Registration or clearance is a market-access fact, never proof of efficacy.

US — FDABiofeedback devices marketed as general-wellness / stress-management.
EU — MDRCE (wellness).
Russia
China — NMPA
Australia — TGA

Sources